Literature DB >> 11472641

A decision analytical cost analysis of offering ECV in a UK district general hospital.

M James1, K Hunt, R Burr, R Johanson.   

Abstract

OBJECTIVE: To determine the care pathways and implications of offering mothers the choice of external cephalic version (ECV) at term for singleton babies who present with an uncomplicated breech pregnancy versus assisted breech delivery or elective caesarean.
DESIGN: A prospective observational audit to construct a decision analysis of uncomplicated full term breech presentations.
SETTING: The North Staffordshire NHS Trust.
SUBJECTS: All women (n = 176) who presented at full term with a breech baby without complications during July 1995 and June 1997. MAIN OUTCOME MEASURES: The study determined to compare the outcome in terms of the costs and cost consequences for the care pathways that resulted from whether a women chose to accept the offer of ECV or not. All the associated events were then mapped for the two possible pathways. The costs were considered only within the hospital setting, from the perspective of the health care provider up to the point of delivery.
RESULTS: The additional costs for ECV, assisted breech delivery and elective caesarean over and above a normal birth were 186.70 pounds sterling, 425.36 pounds sterling and 1,955.22 pounds sterling respectively. The total expected cost of the respective care pathways for "ECV accepted" and "ECV not accepted" (including the probability of adverse events) were 1,452 pounds sterling and 1,828 pounds sterling respectively, that is the cost of delivery through the ECV care pathways is less costly than the non ECV delivery care pathway.
CONCLUSIONS: Implementing an ECV service may yield cost savings in secondary care over and above the traditional delivery methods for breech birth of assisted delivery or caesarean section. The scale of these expected cost savings are in the range of 248 pounds sterling to 376 pounds sterling per patient. This converts to a total expected cost saving of between 43,616 pounds sterling and 44,544 pounds sterling for the patient cohort considered in this study.

Entities:  

Mesh:

Year:  2001        PMID: 11472641      PMCID: PMC35287          DOI: 10.1186/1472-6963-1-6

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  10 in total

1.  How does the mode of delivery affect the cost of maternity care?

Authors:  L Clark; M Mugford; C Paterson
Journal:  Br J Obstet Gynaecol       Date:  1991-06

Review 2.  Impact of caesarean section on future pregnancy--a review of cohort studies.

Authors:  E Hemminki
Journal:  Paediatr Perinat Epidemiol       Date:  1996-10       Impact factor: 3.980

3.  Cesarean section in the United States: has it changed since 1979?

Authors:  H I Marieskind
Journal:  Birth       Date:  1989-12       Impact factor: 3.689

Review 4.  Management of the selected term breech presentation: assessment of the risks of selected vaginal delivery versus cesarean section for all cases.

Authors:  P Bingham; R J Lilford
Journal:  Obstet Gynecol       Date:  1987-06       Impact factor: 7.661

5.  Trends in the frequency of cesarean births.

Authors:  E H Philipson; M G Rosen
Journal:  Clin Obstet Gynecol       Date:  1985-12       Impact factor: 2.190

Review 6.  Reductions in cost and cesarean rate by routine use of external cephalic version: a decision analysis.

Authors:  D S Gifford; E Keeler; K L Kahn
Journal:  Obstet Gynecol       Date:  1995-06       Impact factor: 7.661

Review 7.  Efficacy of external cephalic version: a review.

Authors:  J Zhang; W A Bowes; J A Fortney
Journal:  Obstet Gynecol       Date:  1993-08       Impact factor: 7.661

8.  The introduction of external cephalic version at term into routine clinical practice.

Authors:  S Bewley; S C Robson; M Smith; A Glover; J A Spencer
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-12-15       Impact factor: 2.435

9.  Determining the clinical efficacy and cost savings of successful external cephalic version.

Authors:  J G Mauldin; P D Mauldin; T I Feng; E K Adams; V L Durkalski
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

Review 10.  Interventions to help external cephalic version for breech presentation at term.

Authors:  G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2002
  10 in total
  5 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Reducing the cesarean delivery rates for breech presentations: administration of spinal anesthesia facilitates manipulation to cephalic presentation, but is it cost saving?

Authors:  Carolyn F Weiniger; Paul S Spencer; Yuval Weiss; Gary Ginsberg; Yossef Ezra
Journal:  Isr J Health Policy Res       Date:  2014-02-24

3.  Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis.

Authors:  David Wastlund; Alexandros A Moraitis; Alison Dacey; Ulla Sovio; Edward C F Wilson; Gordon C S Smith
Journal:  PLoS Med       Date:  2019-04-16       Impact factor: 11.069

4.  Cost-effectiveness of external cephalic version for term breech presentation.

Authors:  Jonathan M Tan; Alex Macario; Brendan Carvalho; Maurice L Druzin; Yasser Y El-Sayed
Journal:  BMC Pregnancy Childbirth       Date:  2010-01-21       Impact factor: 3.007

5.  A Systematic Review and Meta-analysis of Clinical Trials of Neuraxial, Intravenous, and Inhalational Anesthesia for External Cephalic Version.

Authors:  Qingzhong Hao; Yirui Hu; Li Zhang; John Ross; Sarah Robishaw; Christine Noble; Xianren Wu; Xiaopeng Zhang
Journal:  Anesth Analg       Date:  2020-12       Impact factor: 6.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.